Fol. Biol. 2013, 59, 168-171
https://doi.org/10.14712/fb2013059040168
Tagging rs10811661 Variant at CDKN2A/2B Locus Is Not Associated with Type 2 Diabetes Mellitus in Czech Population
References
1. , X. Y., Xie, C., Yang, M. S. (2012) Association between type 2 diabetes and CDKN2A/B: a meta-analysis study. Mol. Biol. Rep. 39, 1609-1616.
<https://doi.org/10.1007/s11033-011-0900-5>
2. , D. T., Demenais, F., Iles, M. M., Harland, M., Taylor, J. C., Corda, E., Randerson-Moor, J., Aitken, J. F., Avril, M. F., Azizi, E., Bakker, B., Bianchi-Scarrà, G., Bressac-de Paillerets, B., Calista, D., Cannon-Albright, L. A., Chin-A-Woeng, T., Debniak, T., Galore-Haskel, G., Ghiorzo, P., Gut, I., Hansson, J., Hocevar, M., Höiom, V., Hopper, J. L., Ingvar, C., Kanetsky, P. A., Kefford, R. F., Landi, M. T., Lang, J., Lubiński, J., Mackie, R., Malvehy, J., Mann, G. J., Martin, N. G., Montgomery, G. W., van Nieuwpoort, F. A., Novakovic, S., Olsson, H., Puig, S., Weiss, M., van Workum, W., Zelenika, D., Brown, K. M., Goldstein, A. M., Gillanders, E. M., Boland, A., Galan, P., Elder, D. E., Gruis, N. A., Hayward, N. K., Lathrop, G. M., Barrett, J. H., Bishop, J. A. (2009) Genome-wide association study identifies three loci associated with melanoma risk. Nat. Genet. 41, 920-925.
<https://doi.org/10.1038/ng.411>
3. , P., Novota, P., Černá, M., Kološtová, K., Nováková, D., Kučera, P., Novák, J., Anděl, M., Weber, P., Žďárský, E. (2007) KCNJ11 E23K polymorphism and diabetes mellitus with adult onset in Czech patients. Folia Biol. (Praha) 53, 173-175.
4. , P., Novota, P., Cerna, M., Kolostova, K., Novakova, D., Kucera, P., Novak, J., Andel, M., Weber, P., Zdarsky, E. (2008) HLA DRB1, DQB1 and insulin promoter VNTR polymorphisms: interactions and the association with adult-onset diabetes mellitus in Czech patients. Int. J. Immunogenet. 35, 133-140.
<https://doi.org/10.1111/j.1744-313X.2008.00749.x>
5. , D., Gianfagna, F., Santimone, I., de Gaetano, G., Donati, M. B., Iacoviello, L., Di Castelnuovo, A. (2012) Type 2 diabetes and polymorphisms on chromosome 9p21: a meta-analysis. Nutr. Metab. Cardiovasc. Dis. 22, 619-625.
<https://doi.org/10.1016/j.numecd.2010.11.010>
6. , D., Hubáček, J. A. (2012) FTO gene and its role in genetic determination of obesity. Vnitr. Lek. 58, 208-215. (in Czech with English abstract)
7. , A. S., Dannfald, J., Kimber, C. H., Donnelly, L. A., Pearson, E., Morris, A. D., Palmer, C. N. (2009) The FTO gene is associated with an atherogenic lipid profile and myocardial infarction in patients with type 2 diabetes: a Genetics of Diabetes Audit and Research study in Tayside Scotland (Go-DARTS) study. Circ. Cardiovasc. Genet. 2, 255-259.
<https://doi.org/10.1161/CIRCGENETICS.108.822320>
8. , T., Horová, E., Möllsten, A., Seman, N. A., Falhammar, H., Prázný, M., Brismar, K., Gu, H. F. (2012) IGF2BP2 and IGF2 genetic effects in diabetes and diabetic nephropathy. J. Diabetes Complications 26, 393-398.
<https://doi.org/10.1016/j.jdiacomp.2012.05.012>
9. , C., Rathmann, W., Strassburger, K., Finner, H., Grallert, H., Huth, C., Meisinger, C., Gieger, C., Martin, S., Giani, G., Scherbaum, W. A., Wichmann, H. E., Illig, T. (2008) Variants of the PPARG, IGF2BP2, CDKAL1, HHEX, and TCF7L2 genes confer risk of type 2 diabetes independently of BMI in the German KORA studies. Horm. Metab. Res. 40, 722-726.
<https://doi.org/10.1055/s-2008-1078730>
10. , E., Prázný, M., Kaňková, K., Brismar, K., Gu, H. F. (2012) Genetic and functional analyses of MRAS and HNF1A genes in diabetes and diabetic nephropathy. Folia Biol. (Praha) 58, 121-127.
11. , J. A., Stanek, V., Gebauerová, M., Pilipcincová, A., Dlouhá, D., Poledne, R., Aschermann, M., Skalická, H., Matousková, J., Kruger, A., Penicka, M., Hrabáková, H., Veselka, J., Hájek, P., Lánská, V., Adámková, V., Pitha, J. (2010) A FTO variant and risk of acute coronary syndrome. Clin. Chim. Acta 411, 1069-1072.
<https://doi.org/10.1016/j.cca.2010.03.037>
12. , J. A., Pelikánová, T., Lánská, V., Komers, R. (2011) A polymorphism in the cyclooxygenase 2 gene in type 1 diabetic patients with nephropathy. Physiol. Res. 60, 377-380.
<https://doi.org/10.33549/physiolres.932016>
13. , J. A., Staněk, V., Gebauerová, M., Poledne, R., Aschermann, M., Skalická, H., Matoušková, J., Kruger, A., Pěnička, M., Hrabáková, H., Veselka, J., Hájek, P., Lánská, V., Adámková, V., Piťha, J. (2012a) Association between a marker on chromosome 9 and acute coronary syndrome. Confirmatory study on Czech population. Folia Biol. (Praha) 58, 203-208.
14. J. A., Viklicky, O., Dlouha, D., Bloudickova, S., Kubinova, R., Peasey, A., Pikhart, H., Adamkova, V., Brabcova, I., Pokorna, E., Bobak, M. (2012b) The FTO gene polymorphism is associated with end-stage renal disease: two large independent case-control studies in a general population. Nephrol. Dial. Transplant. 27, 1030-1035.
<https://doi.org/10.1093/ndt/gfr418>
15. , M., Maeda, S. (2011) Genetics of type 2 diabetes: the GWAS era and future perspectives. Endocr. J. 58, 723-739.
<https://doi.org/10.1507/endocrj.EJ11-0113>
16. , J. A., Schiöth, H. B., Fredriksson, R. (2012) The impact of intronic single nucleotide polymorphisms and ethnic diversity for studies on the obesity gene FTO. Obes. Rev. 13, 1096-1109.
<https://doi.org/10.1111/j.1467-789X.2012.01025.x>
17. , V., Vasků, A., Meluzín, J., Panovský, R., Seménka, J., Groch, L. (2009) Association of the eNOS 4a/b and -786T/ C polymormphisms with coronary artery disease, obesity and diabetes mellitus. Folia Biol. (Praha) 55, 187-191.
18. , M., Groen, E. J., van Vught, P. W., van Rheenen, W., Witteveen, E., van Es, M. A., Pasterkamp, R. J., van den Berg, L. H., Veldink, J. H. (2013) Screening for rare variants in the coding region of ALS-associated genes at 9p21.2 and 19p13.3. Neurobiol. Aging 34, 1518.e5-7.
<https://doi.org/10.1016/j.neurobiolaging.2012.09.018>
19. Li, H., Tang, X., Liu, Q., Wang, Y. (2012) Association between type 2 diabetes and rs10811661 polymorphism up-stream of CDKN2A/B: a meta-analysis. Acta Diabetol.
<https://doi.org/10.1017/s00592-012-0400-7>
20. , P., Včelák, J., Vaňková, M., Vejražková, D., Andělová, K., Bendlová, B. (2008) Screening of mutations and polymorphisms in the glucokinase gene in Czech diabetic and healthy control populations. Physiol. Res. 57 (Suppl 1), S99-S108.
<https://doi.org/10.33549/physiolres.931494>
21. , G. E., Melillo, S., Bradley, L. A. (2010) Association between 9p21 genomic markers and heart disease: a metaanalysis. JAMA 303, 648-656.
<https://doi.org/10.1001/jama.2010.118>
22. , E., Sabbagh, A., Vidaud, M., Bièche, I. (2011) ANRIL, a long, noncoding RNA, is an unexpected major hotspot in GWAS. FASEB J. 25, 444-448.
<https://doi.org/10.1096/fj.10-172452>
23. , D. K., Blackett, P. R. (2012) Type 2 diabetes genetics: beyond GWAS. J. Diabetes Metab. 3, 198.
<https://doi.org/10.4172/2155-6156.1000198>
24. , J., Vejražková, D., Vaňková, M., Lukášová, P., Bradnová, O., Hálková, T., Bešťák, J., Andělová, K., Kvasničková, H., Hoskovcová, P., Vondra, K., Vrbíková, J., Bendlová, B. (2012) T2D risk haplotypes of the TCF7L2 gene in the Czech population sample: the association with free fatty acids composition. Physiol. Res. 61, 229-240.
<https://doi.org/10.33549/physiolres.932272>
25. , M., Jenkins, R. B., Chang, J. S., Yeh, R. F., Xiao, Y., Decker, P. A., Ballman, K. V., Berger, M., Buckner, J. C., Chang, S., Giannini, C., Halder, C., Kollmeyer, T. M., Kosel, M. L., LaChance, D. H., McCoy, L., O’Neill, B. P., Patoka, J., Pico, A. R., Prados, M., Quesenberry, C., Rice, T., Rynearson, A. L., Smirnov, I., Tihan, T., Wiemels, J., Yang, P., Wiencke, J. K. (2009) Variants in the CDKN2B and RTEL1 regions are associated with high-grade glioma susceptibility. Nat. Genet. 41, 905-908.
<https://doi.org/10.1038/ng.408>
